Related references
Note: Only part of the references are listed.Growth and capacity for cost-effectiveness analysis in Africa
Ari D. Panzer et al.
HEALTH ECONOMICS (2020)
Analyzing the Cost Effectiveness of Policy Responses for COVID-19: The Importance of Capturing Social Consequences
David Daeho Kim et al.
MEDICAL DECISION MAKING (2020)
Advances in Methods and Novel Applications for Measuring Family Spillover Effects of Illness
Lisa A. Prosser et al.
PHARMACOECONOMICS (2019)
Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer's Disease Interventions
Pei-Jung Lin et al.
PHARMACOECONOMICS (2019)
Quantifying Family Spillover Effects in Economic Evaluations: Measurement and Valuation of Informal Care Time
Scott D. Grosse et al.
PHARMACOECONOMICS (2019)
Cost-effectiveness of raising alcohol excise taxes to reduce the injury burden of road traffic crashes
Linda J. Cobiac et al.
INJURY PREVENTION (2019)
The Inclusion of Spillover Effects in Economic Evaluations: Not an Optional Extra
Werner B. F. Brouwer
PHARMACOECONOMICS (2019)
Family Spillover Effects in Pediatric Cost-Utility Analyses
Tara A. Lavelle et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2019)
Cost-effectiveness analysis of patient self-testing therapy of oral anticoagulation
Sutat Kantito et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2018)
Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh
Abdur Razzaque Sarker et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach
Wail A. Hayajneh et al.
BMC INFECTIOUS DISEASES (2018)
Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell Carcinoma
David J. Sher et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
The Cost-Effectiveness of Surgical Fixation of Distal Radial Fractures
Prashant V. Rajan et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2018)
Cost-effectiveness of dengue vaccination in ten endemic countries
Wu Zeng et al.
VACCINE (2018)
Cost-effectiveness of sex-neutral HPV-vaccination in Sweden, accounting for herd-immunity and sexual behaviour
Ellen Wolff et al.
VACCINE (2018)
An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2]
Louis P. Garrison et al.
VALUE IN HEALTH (2018)
Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy
Francesco Saverio Mennini et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America
Noopur Raje et al.
JOURNAL OF MEDICAL ECONOMICS (2018)
Future Directions for Cost-effectiveness Analyses in Health and Medicine
Peter J. Neumann et al.
MEDICAL DECISION MAKING (2018)
Consensus-based cross-European recommendations for the identification, measurement and valuation of costs in health economic evaluations: a European Delphi study
Lisanne I. van Lier et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2018)
Allocating provider resources to diagnose and treat restless legs syndrome: a cost-utility analysis
William V. Padula et al.
SLEEP MEDICINE (2017)
Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States
Sun-Young Kim et al.
VACCINE (2017)
Cost-Effectiveness of Craniotomy for Epidural Hematomas at a Major Government Hospital in Cambodia
Dane Moran et al.
WORLD JOURNAL OF SURGERY (2017)
Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries
Emelie Heintz et al.
PHARMACOECONOMICS (2016)
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses Second Panel on Cost-Effectiveness in Health and Medicine
Gillian D. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought
Thomas Wilkinson et al.
VALUE IN HEALTH (2016)
A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted
Peter J. Neumann et al.
PLOS ONE (2016)
Cost-effectiveness of rotavirus vaccination in Kenya and Uganda
Charles Sigei et al.
VACCINE (2015)
The Changing Face of the Cost-Utility Literature, 1990-2012
Peter J. Neumann et al.
VALUE IN HEALTH (2015)
Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies
Marieke Krol et al.
PHARMACOECONOMICS (2015)
Economic analysis for evidence-based policy-making on a national immunization program: A case of rotavirus vaccine in Thailand
Charung Muangchana et al.
VACCINE (2012)
Do Productivity Costs Matter? The Impact of Including Productivity Costs on the Incremental Costs of Interventions Targeted at Depressive Disorders
Marieke Krol et al.
PHARMACOECONOMICS (2011)
Cost-effectiveness of Weight Watchers and the Lighten Up to a Healthy Lifestyle program
Linda Cobiac et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH (2010)
Costing and Perspective in Published Cost-Effectiveness Analysis
Peter J. Neumann
MEDICAL CARE (2009)
Completing Costs Patients' Time
Louise B. Russell
MEDICAL CARE (2009)
Should the consumption of survivors be included as a cost in cost-utility analysis?
JA Nyman
HEALTH ECONOMICS (2004)
Cost-effectiveness analysis: Can we reduce variability in costing methods?
T Adam et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2003)
Measuring costs in cost-utility analyses -: Variations in the literature
PW Stone et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2000)